Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BVMF/VRTX34 stock hub

BVMF/VRTX34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BVMF/VRTX34is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
534.3B
Brazil Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
BVMF/VRTX34
In the news

Latest news · BVMF/VRTX34

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E21.5
P25 11.3P50 14.6P75 19.6
Trailing P/E23.6
P25 15.2P50 21.5P75 27.3
ROE24.2
P25 5.3P50 12.3P75 22.5
ROIC28.6
P25 7P50 12.5P75 22.1
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BVMF/VRTX34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
209
Groups with data
11
Currency
USD
Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
United States
Country code
BR
Employees
6,400
Employees Change
700%
Employees Change Percent
12.96
Enterprise value
BRL 480.4B
Exchange
Brazil Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biotechnology
Last refreshed
2026-05-10
Market cap
BRL 534.3B
Price
BRL 523
Price currency
BRL
Rev Per Employee
9,959,054.07x
Sector
Healthcare
Sic
2836
Symbol
bvmf/VRTX34
Website
https://www.vrtx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
4.24%
EV Earnings
21.23x
EV/EBIT
20.45x
EV/EBITDA
18.68x
EV/FCF
24.82x
EV/Sales
8.03x
FCF yield
3.62%
Forward P/E
21.46x
P/B ratio
5.29x
P/E ratio
23.61x
P/S ratio
8.38x
PE Ratio10 Y
50.67x
PE Ratio3 Y
27.83x
PE Ratio5 Y
25.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

23
MetricValue
EBIT Margin
39.25%
EBITDA Margin
40.77%
FCF margin
30.37%
Gross margin
54.39%
Gross Profit
BRL 34.7B
Gross Profit Growth
16.02%
Gross Profit Growth Q
14.36%
Gross Profit Growth3 Y
6.91%
Gross Profit Growth5 Y
11.76%
Net Income
BRL 22.6B
Net Income Growth Q
59.59%
Net Income Growth3 Y
10%
Net Income Growth5 Y
9.45%
Pretax Margin
42.28%
Profit Margin
35.51%
Profit Per Employee
BRL 3.5M
ROA
12.14
Roa5y
14.82
ROCE
21.21
ROE
24.2
Roe5y
19
ROIC
28.57
Roic5y
37.75

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

16
MetricValue
Cagr1y
-15.55%
Cagr3y
6.89%
Cagr5y
13.49%
EPS Growth Q
61.45
EPS Growth3 Y
10.35
EPS Growth5 Y
9.96
FCF Growth Q
66.37%
FCF Growth3 Y
-1.57%
FCF Growth5 Y
4.01%
OCF Growth Q
74.39%
OCF Growth3 Y
1.35%
OCF Growth5 Y
4.77%
Revenue Growth
10.08x
Revenue Growth Q
7.82x
Revenue Growth3 Y
9.89x
Revenue Growth5 Y
13.75x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
BRL 0.5
Assets
BRL 138.2B
Cash
BRL 37.8B
Current Assets
BRL 57.6B
Current Liabilities
BRL 19.1B
Debt
BRL 10.4B
Debt EBITDA
BRL 0.38
Debt Equity
BRL 0.1
Debt FCF
BRL 0.54
Equity
BRL 101B
Interest Coverage
360.5
Liabilities
BRL 37.2B
Long Term Assets
BRL 80.5B
Long Term Liabilities
BRL 18.1B
Net Cash
BRL 57.4B
Net Cash By Market Cap
BRL 10.75
Net Cash Growth
13.41%
Net Debt EBITDA
BRL -2.21
Net Debt Equity
BRL -0.57
Net Debt FCF
BRL -2.97
Tangible Book Value
BRL 93.1B
Tangible Book Value Per Share
BRL 366
WACC
6.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
3.02
Inventory Turnover
3.56
Net Working Capital
BRL 3.1B
Quick ratio
2.38
Working Capital
BRL 40.9B
Working Capital Turnover
BRL 9.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
0.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
-15.54%
200-day SMA
587.6
3Y total return
22.13%
50-day SMA
579.4
50-day SMA vs 200-day SMA
50under200
5Y total return
88.23%
All Time High
748.5
All Time High Change
-29.68%
All Time High Date
2024-11-08
All Time Low
162.4
All Time Low Change
224.15%
All Time Low Date
2019-06-03
ATR
6.59
Beta
0.37
Ch YTD
-15.92
High
526.3
High52
669
High52 Date
2025-07-10
High52ch
-21.87%
Low
522.7
Low52
497.6
Low52 Date
2025-09-23
Low52ch
5.03%
Ma50ch
-9.16%
Price vs 200-day SMA
-10.44%
RSI
32.16
RSI Monthly
43.74
RSI Weekly
36.52
Sharpe ratio
-0.77x
Sortino ratio
-0.82
Total Return
0.15%
Tr YTD
-15.92
Tr1m
-5.18%
Tr1w
-0.84%
Tr3m
-14.89%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
BRL 25B
Operating Income Growth
13.9
Operating Income Growth Q
10.45
Operating Income Growth3 Y
2.39
Operating Income Growth5 Y
9.6
Operating margin
39.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
253,010,542%
Net Borrowing
-26,536,680
Shares Insiders
0.21%
Shares Institutions
94.43%
Shares Qo Q
0.08%
Shares Yo Y
-0.15%
Short Ratio
3.22

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

59
MetricValue
Adjusted FCF
BRL 15.8B
Average Volume
193.25x
Bv Per Share
397.4
CAPEX
BRL -2.8B
Ch1m
-5.18
Ch1w
-0.84
Ch1y
-15.54
Ch3m
-14.89
Ch3y
22.13
Ch5y
88.23
Ch6m
-3.95
Change
-0.69%
Change From Open
-0.69
Close
526.3
Days Gap
0
Depreciation Amortization
914,532,620
Dollar Volume
8,885.4
Earnings Date
2026-05-04
EBIT
BRL 25B
EBITDA
BRL 26B
EPS
BRL 87.96
F Score
6
FCF
BRL 19.4B
FCF EV Yield
4.03x
Financing CF
-11,057,891,983
Fiscal Year End
December
Founded
1,989
Goodwill
5,346,649,600
Graham Number
221.86037
Graham Upside
-57.55
Income Tax
BRL 4.3B
Investing CF
-6,893,902,088
Is Primary Listing
0
Last Earnings Date
2026-05-04
Last Report Date
2026-03-31
Lynch Fair Value
BRL 209
Lynch Upside
-59.97
Ma150
580.2
Ma150ch
-9.3%
Ma20
540.2
Ma20ch
-2.58%
Net CF
4,275,106,138
Open
526.3
P FCF Ratio
27.6
P OCF Ratio
24.15
Position In Range
0
Ppne
16,184,917,700
Price Date
2026-05-08
Price EBITDA
BRL 20.56
Ptbv Ratio
5.74
Relative Volume
0.09x
Revenue
63,737,946,050x
SBC By Revenue
5.62x
Share Based Comp
3,579,716,695
Tax By Revenue
6.77x
Tax Rate
16.02%
Tr6m
-3.95%
Volume
17
Z Score
11.73
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does BVMF/VRTX34 pay a dividend?

Capital-return profile for this ticker.

Performance

BVMF/VRTX34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-15.5%
S&P 500 1Y: n/a
3Y total return
+22.1%
S&P 500 3Y: n/a
5Y total return
+88.2%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns BVMF/VRTX34?

Insider, institutional, and short-interest positioning.

Institutional ownership
+94.4%
Share of float held by funds and institutions
Insider ownership
+0.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
3.2 days to cover
Y/Y dilution
-0.1%
Negative means the company is buying back shares.
Technical

BVMF/VRTX34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
32.2
Neutral momentum band
Price vs 200-day MA
-10.4%
50/200-day relationship not available
Beta (5Y)
0.37
Less volatile than the market
Sharpe ratio
-0.77
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BVMF/VRTX34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/VRTX34 stock rating?

bvmf/VRTX34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/VRTX34 analysis?

The full report lives at /stocks/bvmf/VRTX34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/VRTX34?

The latest report frames bvmf/VRTX34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/VRTX34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.